FXN and Friedreich ataxia: Abeti et al. [136] examined the therapeutic effects of Omav in fibroblasts derived from patients with FRDA, in granule neurons of cerebellums (CGNs) derived from FXN KIKO mice, and in GAA-expanded transgenic Y8GR mice.